Inventor · disambiguated record
Carl K. Edwards, Iii
Also filed as: EDWARDS CARL K · EDWARDS CARL K III · EDWARDS III CARL · EDWARDS III CARL K
23 granted patents·9 pending applications·235 citations·filing 1986–2017
96Inventor score
Files withHOECHST MARION ROUSSEL INC9AMGEN INC5DNX BIOTECH LLC2EDWARDS III CARL KEITH2INT MINERALS & CHEM CORP2
Top patents by PatentIndex Score
32 records- 0190US5244896ACarbocyclic adenosine analogs useful as immunosuppressantsMARION MERRELL DOW INC·Filed 1992·Granted Sep 14, 1993·42 cites·3 claims
- 0280US6989147B2Truncated soluble tumor necrosis factor type-I and type-II receptorsAMGEN INC·Filed 2001·Granted Jan 24, 2006·19 cites·27 claims
- 0378US5905085ATrans cyclopentanyl deazaadenyl analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1997·Granted May 18, 1999·18 cites·24 claims
- 0469US7732587B2Nucleic acids encoding truncated soluble tumor necrosis factorAMGEN INC·Filed 2005·Granted Jun 8, 2010·1 cites·13 claims
- 0567US4837202AMethod for stimulating the immune systemPITMAN MOORE INC·Filed 1987·Granted Jun 6, 1989·16 cites·11 claims
- 0666US5817672ATrans cyclopentanyl purine analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Oct 6, 1998·9 cites·22 claims
- 0764US5817660ATrans cyclopentanyl purine analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Oct 6, 1998·8 cites·22 claims
- 0864US5723466ATrans cyclopentanyl purine analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Mar 3, 1998·8 cites·24 claims
- 0963US5624930ACarbocyclic nucleoside analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Apr 29, 1997·7 cites·18 claims
- 1061US5817661ATrans cyclopentanyl purine analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Oct 6, 1998·7 cites·19 claims
- 1159US5470857ACarbocyclic nucleoside analogs useful as immunosuppressantsMARION MERRELL DOW INC·Filed 1994·Granted Nov 28, 1995·16 cites·24 claims
- 1256US6541482B2Carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokinesFiled 1995·Granted Apr 1, 2003·13 cites·22 claims
- 1353US5514688ACarbocyclic adenosine analogs useful as immunosuppressantsMERRELL DOW PHARMA·Filed 1994·Granted May 7, 1996·14 cites·17 claims
- 1450US2004047863A1Combination therapy using a TNF binding protein for treating TNF-mediated diseasesAMGEN INC·Filed 2003·Application pending·0 cites
- 1550US2004048799A1Combination therapy using a TNF binding protein for treating TNF-mediated diseasesAMGEN INC·Filed 2003·Application pending·0 cites
- 1650US2008027000A1APO-A-I Regulation of T-Cell SignalingDAYER JEAN-MICHEL·Filed 2007·Application pending·0 cites
- 1748US5605903ACarbocyclic nucleoside analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Feb 25, 1997·8 cites·12 claims
- 1848US4842862AImmunostimulating agentsINT MINERALS & CHEM CORP·Filed 1986·Granted Jun 27, 1989·14 cites·18 claims
- 1948US2010168210A1T-Cell Cytokine-Inducing Surface Molecules and Methods of UseEDWARDS III CARL KEITH·Filed 2008·Application pending·0 cites
- 2046US2002119924A1Combination therapy using a TNF binding protein for treating TNF-mediated diseasesAMGEN INC·Filed 2001·Application pending·0 cites
- 2145US6436947B1Trans cyclopentanyl purine analogs useful as immunosuppressantsAVENTIS PHARMA INC·Filed 1997·Granted Aug 20, 2002·2 cites·39 claims
- 2245US5929079ATrans cyclopentanyl azaadenyl analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1997·Granted Jul 27, 1999·2 cites·26 claims
- 2345US2002064820A1Apo-A-I regulation of T-cell signalingFiled 2001·Application pending·0 cites
- 2444US6420373B19-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokinesMERRELL PHARMA INC·Filed 1995·Granted Jul 16, 2002·6 cites·33 claims
- 2543US5631258AMethod of effecting immunosuppression by administering carbocyclic adenosine analogsMERRELL PHARMA INC·Filed 1995·Granted May 20, 1997·6 cites·20 claims
- 2640US2018066049A1Increasing the half-life of a full-length or a functional fragment of variant anti-human TNF-alpha antibodyDNX BIOTECH LLC·Filed 2017·Application pending·0 cites
- 2739US6419919B2Method for the augmentation of gene expressionFiled 1998·Granted Jul 16, 2002·5 cites·12 claims
- 2839US2018028612A1Compositions and methods of using a soluble TNF-alpha receptor modified for increased half-lifeDNX BIOTECH LLC·Filed 2017·Application pending·0 cites
- 2938US5028591AMethod for stimulating the immune systemPITMAN MOORE INC·Filed 1989·Granted Jul 2, 1991·8 cites·7 claims
- 3035US4778821AMethod for controlling helmintic parasitesINT MINERALS & CHEM CORP·Filed 1987·Granted Oct 18, 1988·6 cites·14 claims
- 3134US5916892ATrans cyclopentanyl deazaadenyl analogs useful as immunosuppressantsHOECHST MARION ROUSSEL INC·Filed 1997·Granted Jun 29, 1999·0 cites·26 claims
- 3233US2010278829A1Dual inhibition of immunophilin/cyclophilin family members and emmprin immunoglobulin receptor superfamily membersEDWARDS III CARL KEITH·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →